Tuberculosis is a stern, difficult to treat chronic infection caused by acid-fast bacilli that tend
to take a long time to be eradicated from the host's environment. It requires the action of both …

Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is an infectious disease
that poses severe threats to global public health and significant economic losses. The …

Abstract Ethnopharmacological relevance Traditional Chinese medicine Yifei Tongluo
Granules has been employed clinically with the combination of chemotherapy agents to treat …

Plasma cytokines are biomarkers of disease extent and mycobacterial burden in pulmonary
tuberculosis (PTB). Whether chemokines can perform the same role in PTB is not known. We …

In December 2019, a novel pneumonic condition, Coronavirus disease 2019 (COVID-19)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), broke out in …

The rapid and persistent increase of drug-resistant Mycobacterium tuberculosis (Mtb)
infections poses increasing global problems in combatting tuberculosis (TB), prompting for …

Tuberculosis (TB) has been a transmittable human disease for many thousands of years,
and M. tuberculosis is again the number one cause of death worldwide due to a single …

Cytokine receptors are critical regulators of the antimycobacterial immune response, playing
a key role in initiating and coordinating the recruitment and activation of immune cells during …

The interferon (IFN)-induced transmembrane (IFITM) proteins are critical mediators of the
host antiviral response. Here, we expand the role of IFITM proteins to host defense against …

Klebsiella pneumoniae is a notorious nosocomial pathogen causing a wide range of
infections. The increasing trend of antimicrobial resistance obtained by the species …